Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User (Hospitals, Cancer Research Institute), 2022-2030

The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 20.30% during 2022-2030. The immuno-oncology market report provides an executive-level overview of the immuno-oncology market worldwide today, with detailed forecasts of key indicators up to 2030.

This market intelligence report offers a thorough, forward-looking analysis of the global immuno-oncology market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.

The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of is expected to grow at a CAGR of more than 19% during the forecast period (2022-2030). Major factors such as an increase in healthcare expenditure, a rise in the prevalence and incidence of cancer, a surge in technological advancement in cancer treatment, and novel product launches are expected to boost market growth during the forecast period.

Scope

• Overview of immuno-oncology including classification of therapy and technologies, regulatory and market access details, and product & company profile
• Immuno-oncology market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the class, end-users, and geographic segments.
• Immuno-oncology market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the key class segments.
• Immuno-oncology market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the end-user segment.
• The competitive landscape: an examination of the positioning of leading players in the immune-oncology market.

Reasons to Buy

• This market intelligence report offers a thorough, forward-looking analysis of the global immuno-oncology market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
• Accompanying the publisher's Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in immuno-oncology markets.
• The report also highlights key class and end-user segments.
• With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
• The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in immuno-oncology market.